- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostatic Hyperplasia in United States
Total 4267 results
-
Tulane UniversityBlue Earth DiagnosticsCompletedMetastatic Castration-resistant Prostate CancerUnited States
-
Duke UniversityExelixisTerminatedProstate Cancer | Prostate Cancer Adenocarcinoma | Non-MetastaticUnited States
-
Henry Ford Health SystemAmerican Cancer Society, Inc.WithdrawnLow or Intermediate Risk Prostate CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBayerCompletedProstate Cancer | Prostate AdenocarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterProgenics Pharmaceuticals, Inc.CompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Cougar Biotechnology, Inc.CompletedProstate Cancer | Prostate NeoplasmsUnited States
-
Massachusetts General HospitalCompletedProstate AdenocarcinomaUnited States
-
Bellicum PharmaceuticalsCompletedCastrate Resistent Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Exosome Diagnostics, Inc.Yale UniversitySuspendedMetastatic Castrate Resistant Prostate CancerUnited States
-
Jodi Layton, MDEMD SeronoTerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
David M LubaroffUnited States Department of DefenseCompletedHormone Refractory Prostate CancerUnited States
-
Duke UniversityUnited States Department of DefenseCompletedMetastatic Hormone Refractory Prostate CancerUnited States
-
The University of Texas Health Science Center at...WithdrawnMetastatic Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate Adenocarcinoma | Castrate Resistant Prostate CancerUnited States
-
Timothy HoffmanUniversity of Missouri-Columbia; Harry S. Truman Memorial Veterans' Hospital; Telix Pharmaceuticals, LtdTerminatedProstate Cancer | Prostate AdenocarcinomaUnited States
-
University of Texas Southwestern Medical CenterCompletedmCRPC | Metastatic Castrate-resistant Prostate CancerUnited States
-
Cancer Center of IrvineUnknown
-
GenesisCare USADendreonCompletedCastrate Refractory Metastatic Prostate Cancer (mCRPC)United States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Progressive Castration-resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)Completed
-
University of PennsylvaniaCastleman Disease Collaborative NetworkCompletedHyperplasia | Castleman Disease | Castleman's Disease | Giant Lymph Node Hyperplasia | Angiofollicular Lymph Hyperplasia | Angiofollicular Lymphoid Hyperplasia | GLNHUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedCastration-resistant Prostate Cancer | Stage IV Prostate CancerSingapore, United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedMetastatic Prostate Carcinoma | Metastatic Prostatic Adenocarcinoma | Prostate Carcinoma Metastatic to the BoneUnited States
-
Stanford UniversityNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage III Prostate Cancer | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Stage I Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of ChicagoRecruitingProstate Cancer | Prostate Adenocarcinoma | Prostate NeoplasmUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedEnzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate CancerRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
Mary-Ellen Taplin, MDSanofi; Beth Israel Deaconess Medical Center; Genentech, Inc.; Duke UniversityCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
University of WashingtonNational Cancer Institute (NCI); AstraZenecaTerminatedStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Prostate Adenocarcinoma Without Neuroendocrine DifferentiationUnited States
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedMetastatic Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Hormone-Resistant Prostate CancerUnited States
-
CyberKnife Centers of San DiegoUnknown
-
Terence Friedlander, MDJanssen Biotech, Inc.CompletedCastration Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7United States
-
National Cancer Institute (NCI)CompletedProstatic Neoplasms | Prostate Cancer | Neoplasms of Prostate | Cancer Of Prostate | Stage D0 Prostate CancerUnited States
-
BayerCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)United States
-
POM Wonderful LLCCompletedRecurrent Prostate CancerUnited States
-
Bristol-Myers SquibbCompleted
-
Julie Graff, MDJohns Hopkins University; Merck Sharp & Dohme LLC; Oregon Health and Science... and other collaboratorsRecruitingProstate Cancer | Prostate Cancer MetastaticUnited States
-
Indiana UniversityIndiana University School of MedicineCompletedProstate Cancer RecurrentUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMetastatic Prostate CancerUnited States
-
Global Isotopes, LLC d/b/a Zevacor MolecularCompletedMetastatic Prostate CancerUnited States
-
AstraZenecaCompletedAdvanced Prostate AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Oregon Health and Science UniversityCompletedProstate Cancer | Metastatic, Androgen Independent Prostate CancerUnited States
-
BayerCompletedMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
University of Michigan Rogel Cancer CenterCompleted
-
Duke UniversityBayerCompletedPharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate CancerBone Metastatic Castration-Resistant Prostate CancerUnited States
-
Northwestern UniversityRecruitingMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Refractory Prostate Cancer | Castration-Resistant Prostatic CancerUnited States